Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 08-2021 | 08-2020 | |
| Operating Expenses | 10,108 | 9,930 | 10,287 | 7,441 | 4,686 |
| Operating Income | -10,108 | -9,930 | -10,287 | -7,441 | -4,686 |
| Interest Expense | 0 | 0 | 5 | 0 | 1 |
| Other Income | 282 | 641 | 209 | 4 | 32 |
| Pre-tax Income | -9,826 | -9,289 | -10,083 | -7,437 | -4,655 |
| Net Income Continuous | -9,826 | -9,289 | -10,083 | -7,437 | -4,655 |
| Net Income | $-9,826 | $-9,289 | $-10,083 | $-7,437 | $-4,655 |
| EPS Basic Total Ops | -18.30 | -18.84 | -21.36 | -35.81 | -113.32 |
| EPS Basic Continuous Ops | -18.29 | -18.83 | -21.35 | -35.83 | -112.92 |
| EPS Diluted Total Ops | -18.30 | -18.84 | -21.36 | -35.81 | -113.32 |
| EPS Diluted Continuous Ops | -18.29 | -18.83 | -21.35 | -35.83 | -112.92 |
| EPS Diluted Before Non-Recurring Items | -18.30 | -18.84 | -21.36 | N/A | N/A |
| EBITDA(a) | $-10,108 | $-9,930 | $-10,287 | $-7,441 | $-4,686 |